More from the American Society of Clinical Oncology meeting: GSK (GSK) presents positive results...

|By:, SA News Editor

More from the American Society of Clinical Oncology meeting: GSK (GSK) presents positive results from late-stage trials of its trametinib and dabrafenib treatments for skin cancer, while Bayer's (BAYRY.PK) regorafenib delays progression of stomach cancer.